Jacob Hull Kristensen

Title: Jacob Hull Kristensen: Innovator in Biochemical Markers for Lung Diseases

Introduction

Jacob Hull Kristensen is a notable inventor based in Soborg, Denmark. He has made significant contributions to the field of biomedical research, particularly in the development of methods for diagnosing lung diseases. His innovative work focuses on the quantification of peptide fragments that are elevated in conditions such as Chronic Obstructive Pulmonary Disease (COPD), Squamous Cell Carcinoma (SCC), and Idiopathic Pulmonary Fibrosis (IPF).

Latest Patents

Jacob Hull Kristensen holds a patent for "Biochemical markers for pulmonary and other diseases." This patent provides a method of bioassay for the quantification of peptide fragments elevated in lung diseases. The method involves contacting a sample with an antibody that has a specific binding affinity for a neo-epitope formed at a cleavage site by the in vivo cleavage of elastin by a proteinase. The patent details how the level of binding is determined when the antibody binds to specific terminal sequences, including FGPGVV, VPGLGV, or IKAPKL. Additionally, the patent includes antibodies and immunoassay kits for use in these methods. Jacob Hull Kristensen has 1 patent to his name.

Career Highlights

Jacob Hull Kristensen is associated with Nordic Bioscience A/S, a company that specializes in the development of innovative solutions for the diagnosis and treatment of diseases. His work at Nordic Bioscience A/S has been instrumental in advancing the understanding of biochemical markers related to lung diseases.

Collaborations

Jacob collaborates with esteemed colleagues, including Diana Julie Oersnes-Leeming and Morten A Karsdal. Their combined expertise contributes to the innovative research and development efforts at Nordic Bioscience A/S.

Conclusion

Jacob Hull Kristensen is a prominent figure in the field of biomedical innovation, particularly in the area of lung disease diagnostics. His contributions through his patent and work at Nordic Bioscience A/S highlight the importance of research in improving health outcomes.